Impact of H63D mutations, magnetic resonance and metabolic syndrome among outpatient referrals for elevated serum ferritin in the Basque Country.

Castiella A, Zapata E, Zubiaurre L, Alustiza JM, De Juan,MD, Iribarren A, Emparanza JI, Otazua P.

Ann. Hepatol. 2015; 14: 333-339. FI: 2.065 (Q3).

MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.

Erice O, Smith MP, White R, Goicoechea I, Barriuso J, Jones C, Margison GP, Acosta JC, Wellbrock C, Arozarena I.

Mol. Cancer Ther. 2015; 14: 1236-1246. FI: 5.683 (Q1).

Methods for extracellular vesicles isolation in a hospital setting.

Saenz-Cuesta M, Arbelaiz A, Oregi A, Irizar H, Osorio-Querejeta I, Munoz-Culla M, Banales JM, Falcon-Perez JM, Olascoaga J, Otaegui D.

Front. Immunol. 2015; 6. FI: 5.695 (Q1).

Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain.

Turnes J, Diaz R, Hernandez-Guerra M, Gomez M, Castells L, Bustamante J, Espinosa, MD,Fernandez-Castroagudin J, Serrano T, Rendon P, Andrade R, Salgado M, Arenas J, Vergara M, Sala M, Polo BA, Granizo IM, Gonzalvez ML, Viudez A.

Gastroenterol. Hepatol. 2015; 38: 263-273. FI: 0.838 (Q4).

Measurement of Liver Iron Concentration by MRI Is Reproducible.

Alustiza JM, Emparanza JI, Castiella A, Casado A, Garrido A, Aldazabal P, San Vicente M, Garcia N, Asensio AB, Banales J, Salvador E, Moyua A, Arozena X, Zarco M, Jauregui L, Vicente O.

Biomed Res. Int. 2015; 2015: 294024-0. FI: 1.579 (Q3).

Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506.

Ananthanarayanan M, Banales JM, Guerra MT, Spirli C, Munoz-Garrido P, Mitchell-Richards K, Tafur D, Saez E, Nathanson MH.

J. Biol. Chem. 2015; 290: 184-196. FI: 4.573 (Q1).

Medición del T2* hepático y cardíaco en la hemocromatosis secundaria.

Barrera MC, Uranga M, Sánchez J, Alústiza JM, Gervás C, Guisasola A.

Radiologia. 2013; 55: 331-339. FI: 0.000 (Q0).

Is MRI becoming the new gold standard for diagnosing iron overload in hemochromatosis and other liver iron disorders?.

Castiella A, Alustiza JM, Zapata E, Emparanza JI.

Imaging Med. 2013; 5: 515-524. FI: 0.000 (Q0).

Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5 T in rats with nonalcoholic fatty liver disease.

Hijona E, Sánchez-González J, Alustiza JM, Hijona L, Arenas J, García E, Rojas N, Portillo MP, Jiménez R, Aldazabal P, Bujanda L.

Eur. J. Radiol. 2012; 81: 1122-1127. FI: 2.606 (Q2).

The Spanish Dili Registry. Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative.

Bessone F, Hernández N, Davalos M, Parana R, Schinoni MI, Lizarzabal M, Kershenobich D, Loaeza A, Arrese M, Chirino RA, Méndez-Sánchez N, Fay F, Bruguera M, Stephens C, Lucena MI, Andrade RJ.

Ann. Hepatol. 2012; 11: 544-549. FI: 1.811 (Q3).

COLONPREV Study Investigators, Spanish Gastroenterological Assoc. Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening.

Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, Andreu M, Carballo F, Morillas JD, Hernández, C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andres M, Teruel G, Peris A, Roncales MP, Polo-Tomas M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Perez-Riquelme F, Alonso-Abreu I, De la Vega-Prieto M, Reyes-Melian, JM, Cacho G, Diaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, Gonzalez-Navarro A.

N. Engl. J. Med. 2012; 366: 697-706. FI: 53.298 (Q1).

Iron Overload and HFE Mutations: Are They Relevant in Cryptogenic Cirrhosis?

Castiella A.

Hepat. Mon. 2012; 12: 126-127. FI: 2.190 (Q3).

Is the role of liver biopsy changing in hemochromatosis? A non invasive approach is ready.

Castiella A, Alustiza JM, Zapata E, Otazua P, Fernández J, Zubiaurre L.

Gastrointest. Liver Dis. 2012; 21: 326-327. FI: 1.811 (Q3).

Mild hepatic iron overload in dysmetabolic hyperferritinemia: MRI may overestimate the liver iron concentration values.

Castiella A, Alustiza JM, Zapata E, Emparanza JI, Otazua P, Zubiaurre L, Aguirre A.

Ann. Hematol. 2012; 91: 961-970. FI: 2.615 (Q2).